Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Reexamination Certificate
2004-06-24
2009-02-03
Allen, Marianne P (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
C530S412000, C530S387100
Reexamination Certificate
active
07485704
ABSTRACT:
A method for reducing leaching of protein A during protein A affinity chromatography is described which involves reducing temperature or pH of, or by adding one or more protease inhibitors to, a composition that is subjected to protein A affinity chromatography.
REFERENCES:
patent: 5622700 (1997-04-01), Jardieu et al.
patent: 5725856 (1998-03-01), Hudziak et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 6127526 (2000-10-01), Blank
patent: 6333398 (2001-12-01), Blank
patent: 6927044 (2005-08-01), Stahl et al.
patent: 95/22389 (1995-08-01), None
patent: WO 96/30046 (1996-10-01), None
patent: WO 98/23645 (1998-06-01), None
patent: WO 98/23761 (1998-06-01), None
patent: WO 98/45331 (1998-10-01), None
patent: WO 01/00245 (2001-01-01), None
patent: WO 03/041859 (2003-05-01), None
patent: WO 2004/076485 (2004-09-01), None
Balint et al., “Evidence for Proteolytic Cleavage of Covalently Bound Protein A from a Silica Based Extracorporeal Immunoadsorbent and Lack of Relationship to Treatment Effects”Transfusion Science16:85-94 (1995).
Fahrner et al., “Expanded bed protein A affinity chromatography of a recombinant humanized monoclonal antibody: process development, operation, and comparison with a packed bed method”Journal of Biotechnology75:273-280 (1999).
Gagnon, P., “Affinity Chromatography: The Fine Print”Validated Quarterly Resource Guide for Downstream Processing(www.validated.com/revalbio/pdffiles/affinity.pdf) pp. 1-5 (1999).
Horenstein et al., “Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle”Journal of Immunological Methods275:99-112 (2003).
Schuler et al., “Development and optimization of a single-step procedure using protein A affinity chromatography to isolate murine IgG monoclonal antibodies from hybridoma supernatants”Journal of Chromatographypp. 61-70 (1991).
Tu et al., “Temperature affects binding of murine monoclonal IgG antibodies to protein A”Journal of Immunological Methods109:43-47 (1988).
van Sommeren et al., “Effects of temperature, flow rate and composition of binding buffer on adsorption of mouse monoclonal IgG1antibodies to protein A Sepharose 4 Fast Flow”Preparative Biochemistry22(2):135-149 (Jun. 1992).
Carter et al., “Humanization of an Anti-p185HER2Antibody For Human Cancer Therapy”Proc. Natl. Acad. Sci. USA89:4285-4289 (May 1992).
Kim et al., “The Vascular Endothelial Growth Factor Proteins: Identification of Biologically Relevant Regions by Neutralizing Monoclonal Antibodies”Growth Factors7(1):53-64 (1992).
Presta et al., “Humanization of an Anti-Vascular Endothelial Growth Factor Monoclonal Antibody for the Therapy of Solid Tumors and Other Disorders”Cancer Research57(20):4593-4599 (Oct. 15, 1997).
Werther et al., “Humanization of an Anti-Lymphocyte Function-Associated Antigen (LFA)-1 Monoclonal Antibody and Reengineering of the Humanized Antibody for Binding to Rhesus LFA-1”J. of Immunology157:4986-4995 (1996).
Fahrner Robert L.
Laverdiere Amy
McDonald Paul J.
O'Leary Rhona M.
Agarwal Atulya R.
Allen Marianne P
Dreger Ginger R.
Genentech Inc.
Goodwin & Procter LLP
LandOfFree
Reducing protein A leaching during protein A affinity... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reducing protein A leaching during protein A affinity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reducing protein A leaching during protein A affinity... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4099106